In pancreatic β-cells, glucose-induced mitochondrial ATP production plays an important role in insulin secretion. The mitochondrial phosphate carrier PiC is a member of the SLC25 (solute carrier family 25) family and transports P i from the cytosol into the mitochondrial matrix. Since intramitochondrial P i is an essential substrate for mitochondrial ATP production by complex V (ATP synthase) and affects the activity of the respiratory chain, P i transport via PiC may be a rate-limiting step for ATP production. We evaluated the role of PiC in metabolism-secretion coupling in pancreatic β-cells using INS-1 cells manipulated to reduce PiC expression by siRNA (small interfering RNA). Consequent reduction of the PiC protein level decreased glucose (10 mM)-stimulated insulin secretion, the ATP:ADP ratio in the presence of 10 mM glucose and elevation of intracellular calcium concentration in response to 10 mM glucose without affecting the mitochondrial membrane potential ( ψ m ) in INS-1 cells. In experiments using the mitochondrial fraction of INS-1 cells in the presence of 1 mM succinate, PiC down-regulation decreased ATP production at various P i concentrations ranging from 0.001 to 10 mM, but did not affect ψ m at 3 mM P i . In conclusion, the P i supply to mitochondria via PiC plays a critical role in ATP production and metabolism-secretion coupling in INS-1 cells.
INTRODUCTION
Glucose stimulates insulin secretion by both triggering and amplifying signals in pancreatic β-cells [1] . The triggering pathway includes entry of glucose into β-cells, acceleration of glycolysis in the cytosol and mitochondrial metabolism of products derived from glycolysis, increase in ATP content and ATP/ADP ratio, closure of ATP-sensitive K + channels (K ATP channels), membrane depolarization, opening of VDCCs (voltage-dependent Ca 2+ channels), increase in Ca 2+ influx through VDCCs, rise in intracellular Ca 2+ concentration ([Ca 2+ ] i ), and exocytosis of insulin granules. Glucose also exerts its effects by increasing Ca 2+ efficacy in stimulation-secretion coupling via an amplifying pathway, owing at least in part to the direct effect of increased ATP derived from glucose metabolism on exocytosis. Since depletion of mitochondrial DNA abolishes the glucose-induced ATP elevation, mitochondria are clearly a major source of ATP production in pancreatic β-cells [2, 3] . Collectively, in pancreatic β-cells, intracellular glucose metabolism regulates exocytosis of insulin granules according to metabolism-secretion coupling in which glucose-induced mitochondrial ATP production plays an important role.
Almost all of the mitochondrial carrier proteins are embedded in the inner membranes of mitochondria, where they transport solutes across the membrane. They belong to the SLC25 (solute carrier family 25) group of proteins [4] . Several members of the SLC25 group have been reported to play roles in GSIS (glucose-stimulated insulin secretion) in pancreatic β-cells. Overexpression or silencing of AGC1 (aspartate/glutamate carrier 1; SLC25A12 or Aralar1) has been reported to increase or reduce GSIS in INS-1E cells respectively [5, 6] . Overexpression of UCP2 (uncoupling protein 2; SLC25A8) by adenovirus vector is known to inhibit GSIS from rat islets [7] , whereas GSIS from islets of UCP2-deficient mice is enhanced compared with that from control islets [8] . In addition, down-regulation of OGC (2-oxoglutarate carrier; SLC25A11), CIC (citrate/isocitrate carrier; SLC25A1) and GC1 (glutamate carrier 1; SLC25A22) by siRNA (small interfering RNA) suppress GSIS [9] [10] [11] .
The mitochondrial phosphate carrier PiC (SLC25A3) is a member of the SLC25 family and transports P i from the cytosol into the mitochondrial matrix. The PiC gene has 9 exons; the 3rd and the 4th exons are called exon 3A and exon 3B respectively. These two exons are alternatively spliced and two isoforms of PiC, PiC-A and PiC-B, are generated [12] . They differ considerably in their kinetic parameters as previously shown in a study using a reconstitution system [13] . The K m of PiC-A for P i on the external membrane surface is 3-fold that of PiC-B (PiC-A: ∼ 2.2 mM; PiC-B: ∼ 0.78 mM). The K m on the internal surface is much higher (PiC-A: ∼ 9.7 mM; PiC-B: ∼ 6.3 mM) than K m on the external membrane surface. The maximum transport rate of PiC-A is approximately a third that of PiC-B. These isoforms also differ in their tissue distribution. PiC-A is expressed in skeletal muscle and cardiac muscle, whereas PiC-B is expressed ubiquitously [13, 14] . A case study of patients with PiC-A deficiency who suffered from lactic acidosis, heart failure and muscle weakness and died within the first year of life, demonstrates the critical significance of this carrier [15] .
Since intramitochondrial P i is an essential substrate for mitochondrial ATP production by complex V (ATP synthase) and affects activity of the respiratory chain [16] , the supply of P i from cytosol to mitochondrial matrix via PiC may be a rate-limiting step for ATP production. However, precise detection of PiC and its significance in metabolism-secretion coupling in pancreatic β-cells has not been reported previously. In the present study, the role of PiC in metabolism-secretion coupling in pancreatic β-cells is evaluated using INS-1 cells manipulated to reduce PiC expression.
EXPERIMENTAL

Materials
ATP, ADP, poly-L-ornithine, DAPP (diadenosine pentaphosphate), Safranin O, FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), ATP sulfurylase and Na 2 MoO 4 were purchased from Sigma. Hepes, KCl, EGTA, sodium pyruvate, MgSO 4 , NaH 2 PO 4 , CaCl 2 , glucose, NaCl, NaHCO 3 , HClO 4 , Na 2 CO 3 , pyruvate kinase, BSA, KOH, potassium gluconate and KH 2 PO 4 were purchased from Nacalai. 2-mercaptoethanol, penicillin, streptomycin and mouse monoclonal antibodies to the subunits of the mitochondrial respiratory chain complexes were purchased from Invitrogen. Luciferin-luciferase was purchased from Promega.
Cell culture
INS-1 (rat insulinoma) cells were cultured in RPMI 1640 medium containing 11.1 mM glucose (Invitrogen) supplemented with 10 % heat-inactivated fetal calf serum, 10 mM Hepes, 2 mM L-glutamine, 1 mM sodium pyruvate, 50 μM 2-mercaptoethanol, 100 IU/ml penicillin and 100 μg/ml streptomycin at 37
• C in a humidified atmosphere (5 % CO 2 and 95 % air). COS-7 (African green monkey kidney) cells were cultured in Dulbeco's modified Eagle's medium supplemented with 10 % heat-inactivated fetal calf serum, 100 IU/ml penicillin and 100 μg/ml streptomycin at 37
• C in a humidified atmosphere (5 % CO 2 and 95 % air).
siRNA transfection
Stealth TM siRNAs were synthesized by Invitrogen. The sequences of siRNAs specific for both rat PiC-A and PiC-B were: 5 -AAAUAUGCCCUUGUACUUCUGAGGG-3 and 5 -CCCUCAGAAGUACAAGGGCAUAUUU-3 designated as PiC siRNA1 and 5 -GAACACCUAUCUGUGGCGUACAUCA-3 and 5 -UGAUGUACGCCACAGAUAGGUGUUC-3 designated as PiC siRNA2. The sequences of control siRNAs were: 5 -ACCAACAACAGUUUGGGAAUAGGGA-3 and 5 -UCCCUAUUCCCAAACUGUUGUUGGU-3 . Cultured INS-1 cells were trypsinized, suspended with RPMI 1640 medium without antibiotics, mixed with Opti-MEM (Invitrogen) containing siRNA and Lipofectamine TM 2000 (Invitrogen), plated on dishes or wells and then incubated at 37
• C in a CO 2 incubator. The final amounts of INS-1 cells, RPMI 1640, Opti-MEM, siRNA and Lipofectamine TM 2000 were 1×10 6 cells/ml, 75 % (v/v), 25 % (v/v), 80 nM and 0.3 % respectively. Medium was replaced with RPMI 1640 3-4 h after transfection. All experiments using siRNA-transfected INS-1 cells were performed 48 h after transfection unless otherwise noted.
Isolation of total RNA and quantitative RT (reverse transcription)-PCR
Total RNA was isolated from cardiac muscle, brain, skeletal muscle, kidney, liver and lung of Wistar rats using TRIzol ® (Invitrogen) and from islets of Wistar rats and INS-1 cells using RNeasy mini kit (Qiagen). Animals were maintained and used • C for 10 min followed by 40 cycles at 95
• C for 30s and 60
• C for 30s.
Plasmid construction and transfection
The cDNA fragment of rat PiC-B was obtained from rat islets by RT-PCR and cloned into the pHMCA5 vector. pHMCA5-PiC-B was transfected into COS-7 and INS-1 cells using FuGENE TM 6 transfection reagent (Roche) and Lipofectamine TM 2000 respectively.
Immunoblot analysis
Rabbit antibody against the rat PiC peptide PPEM-PESLKKKLGLTE corresponding to C-terminal residues was originally raised. For immunoblotting, cells were washed with PBS containing protease inhibitor (Complete; Roche), suspended in 1 ml of PBS containing protease inhibitor and homogenized. Protein (50 μg per sample) was separated on a 15% polyacrylamide gel and transferred to a nitrocellulose membrane. After blocking with TBS (Tris-buffered saline; 10 mM Tris/HCl and 100 mM NaCl, pH 7.5) containing 0.1 % Tween 20 and 5 % skimmed milk (blocking buffer) at room temperature (25 • C) for 2 h, blotted membranes were incubated overnight at 4
• C with anti-PiC antibody at 1:500 dilution, anti-DIC (dicarboxylate carrier) antibody (Novus Biologicals) at 1:100 dilution, mouse monoclonal anti-complex I (39 kDa subunit) antibody, anti-complex III (core II) antibody, anticomplex IV (subunit I) antibody or anti-complex V (subunit α) of mitochondrial respiratory chain antibody at 1:1000 dilution in blocking buffer, and subsequently with anti-rabbit (for PiC and DIC) or anti-mouse (for respiratory chain proteins) IgG horseradish peroxidase-conjugated secondary antibody (GE Healthcare) diluted 1:5000 at room temperature for 2 h prior to detection using ECL (GE Healthcare). In the same membrane, the process was repeated for β-actin at 1:1000 dilution of the antibody. Band intensities were quantified with Multi Gauge software (Fujifilm).
Insulin secretion
For insulin secretion assays, INS-1 cells cultured on 24-well plates coated with 0.001 % poly-L-ornithine were washed with KRBH (Krebs-Ringer bicarbonate Hepes buffer) composed of 140 mM NaCl, 3.6 mM KCl, 0.5 mM MgSO 4 , 0.5 mM NaH 2 PO 4 , 1.5 mM CaCl 2 , 2 mM NaHCO 3 , 0.1% BSA and 10 mM Hepes (pH 7.4) with 2 mM glucose, preincubated at 37
• C for 30 min in KRBH with 2 mM glucose, and then incubated at 37
• C for 30 min in KRBH with 2 mM glucose, 10 mM glucose or 2 mM glucose plus 30 mM KCl. Insulin concentrations were determined by RIA using rat insulin as a standard as previously described [17] .
Adenine nucleotides
ATP and ADP contents were determined as previously described [18, 19] with some modifications. Briefly, INS-1 cells were cultured, washed and preincubated as described above and incubated with KRBH with 2 mM glucose, 10 mM glucose or 2 mM glucose plus 30 mM KCl at 37
• C for 30 min. Incubation was stopped by the addition of HClO 4 . The contents of wells were sonicated [three pulses of 3 s duration using a Handy Sonic UR-20P instrument (TOMY SEIKO) on ice] and transferred into glass tubes. The tubes were then centrifuged, and a fraction of the supernatant was neutralized with Hepes and Na 2 CO 3 . The ATP concentration was measured by luciferin-luciferase assay. After ATP in the neutralized extract was irreversibly converted to AMP with ATP sulfurylase in the presence of Na 2 MoO 4 , ADP in the reactant was converted to ATP with pyruvate kinase and was determined by luciferin-luciferase assay as the difference between the measurements with and without pyruvate kinase. • C for 90 min, placed in a heat-controlled chamber on the stage of an inverted microscope kept at 36 + − 1
• C, superfused with KRBH containing 2 mM glucose, and subsequently exposed to the buffer containing 10 mM glucose or 30 mM KCl. The cells were excited successively at 340 and 380 nm, and the fluorescence emitted at 510 nm was captured by CCD camera (Micro Max 5 MHz System, Roper Industries, Trenton, NJ). The images were analysed with the Meta Fluor image analyzing system (Universal Imaging). The 340 nm (F340) and 380 nm (F380) fluorescence signals were detected every 15 s, and ratios (F340/F380) were calculated. For ψ m measurements, the same protocol as above was used except that cultured cells were loaded with 10 μg/ml rhodamine 123 (Invitrogen) at 37
• C for 30 min and fluorescence excited at 490 nm and emitted at 530 nm every 20 s was monitored.
ATP production and ψ m in mitochondrial fraction
Measurement of ATP production from the mitochondrial fraction was performed as previously described [18] with minor modifications. Firstly, INS-1 cells were homogenized in solution A consisting of 50 mM Hepes, 100 mM KCl, 1.8 mM ATP, 1 mM EGTA, 2 mM MgCl 2 and 0.5 mg/ml BSA (electrophoretically homogeneous) with the pH adjusted to 7.00 at 37
• C with KOH. After precipitation of cell debris and nuclei by 800 g centrifugation for 3 min, the supernatant was centrifuged more rapidly (10 000 g for 3 min) to obtain a pellet containing the mitochondrial fraction. The precipitation, diluted by 200 μl of solution A, was centrifuged again and rinsed three times in solution B, consisting of 20 mM Hepes, 1 mM EGTA, 12 mM NaCl, 0.3 mM MgCl 2 , 130 mM potassium gluconate and 0.5 mg/ml BSA (electrophoretically homogeneous) with the pH adjusted to 7.10 with KOH. The mitochondrial fraction in 500 μl of solution B was kept on ice until use. To measure ATP production by oxidative phosphorylation, the reaction was started by adding mitochondrial suspension to prewarmed solution B (37
• C) containing mitochondrial substrates with or without respiratory chain inhibitors, 50 μM ADP, 1 μM DAPP and various levels of P i . DAPP, a specific inhibitor of adenylate kinase, was used to measure ATP production by oxidative phosphorylation exclusively. After the reaction was stopped, the ATP concentration in the solutions was measured by adding luciferin-luciferase solution with a bioluminometer. ATP production was corrected by mitochondrial protein content. Measurement of ψ m was performed as previously described [20] with some modifications. Fluorescence was successively monitored using a spectrofluorophotometer (RF 5000; Shimadzu) with an excitation wavelength of 495 nm and emission at 586 nm, and with stirring solution B supplemented with 3 mM KH 2 PO 4 , 50 μM ADP and 2.5 μM Safranin O applied in a glass cuvette at 37
• C. Mitochondria, succinate and FCCP were added to the solution in this order and final concentrations were 50 μg/ml, 1 mM and 200 nM respectively.
Statistical analysis
The data are expressed as means + − S.E.M. Statistical significance was calculated by unpaired Student's t test. P < 0.05 was considered significant.
RESULTS
Expression of PiC mRNA in pancreatic β-cells
Tissue distribution of PiC was evaluated by RT-PCR ( Figure 1A ). PiC-B was expressed ubiquitously whereas PiC-A was expressed clearly in cardiac muscle and skeletal muscle as previously reported [13, 14] and obscurely in rat islets and INS-1 cells. These results indicate that PiC-B was dominantly expressed in pancreatic β-cells.
Evaluation of anti-PiC antibody
The cell lysates of COS-7 cells transfected with pHMCA5-PiC or pHMCA5-null, INS-1 cells transfected with pHMCA5-null, intact INS-1 cells and rat islets were electrophoresed and immunoblotted using the anti-PiC antibody. As shown in Figure 1(B) , the band at ∼ 30 kDa, which was not detected in COS-7 cells transfected with pHMCA5-null, was detected in COS-7 cells transfected with pHMCA5-PiC, INS-1 cells transfected with pHMCA5-null, intact INS-1 cells and rat islets. This observation is consistent with a previous report that rat PiC was detected at ∼ 30 kDa by an antibody originally raised using the C-terminal amino acids as the antigen peptide [21] .
Silencing effects of PiC siRNAs on INS-1 cells
Quantitative RT-PCR assays using primers for total PiC (PiC-A plus PiC-B, Table 1 ) and immunoblotting using anti-PiC antibody revealed ∼ 70 % reduction of PiC mRNA expression and ∼ 40 % reduction of the protein expression in INS-1 cells 48 h after both PiC siRNA1 and 2 transfection respectively ( Figures 1C  and 1D ). Time-dependent reduction of PiC protein expression (∼ 25 %, ∼ 40 % and ∼ 50 % reduction at 24 h, 48 h and 72 h after siRNA1 and 2 transfection) implies long half-life of PiC, which causes low efficacy of suppression ( Figure 1D ). Transfection of control siRNA did not affect the expression of PiC in INS-1 cells at both mRNA and protein levels. Protein expressions of DIC, another P i carrier, were not affected by siRNA1 and 2 transfection ( Figure 1E ). Figure 2 . A reduction in GSIS of 61 % by PiC siRNA1 and 47 % by PiC siRNA2 was observed. K + (30 mM)-stimulated insulin secretion was also reduced: the reduction was 27 % by PiC siRNA1 and 23 % by PiC siRNA2, which were milder than those of GSIS ( Figure 2 ). Insulin secretion in the basal glucose state (2 mM) was not affected by PiC siRNA1, but was slightly increased by PiC siRNA2. Transfection of control siRNA did not affect GSIS in INS-1 cells.
Effects of PiC down-regulation on glucose-and depolarization-stimulated insulin secretion
Down-regulation of PiC decreased GSIS (10 mM glucose) in INS-1 cells, as shown in
Effects of PiC down-regulation on adenine nucleotides
Down-regulation of PiC increased ADP and decreased the ATP:ADP ratio, whereas it did not significantly affect ATP in the presence of 10 mM glucose in INS-1 cells (Table 2A) . ATP, ADP and the ATP:ADP ratio at 2 mM glucose was not altered by silencing PiC (Tables 2A and 2B ). Depolarization evoked by 30 mM K + in the presence of 2 mM glucose decreased the ATP:ADP ratio in both control and PiC down-regulated cells, whereas suppression of the ATP:ADP ratio was lower in PiC down-regulated cells compared with control cells (Table 2B) .
Effects of PiC down-regulation on [Ca 2+ ] i and ψ m in living cells
Fluorescence signals of Fura-PE3 revealed that elevation of [Ca 2+ ] i in response to a stimulating level of 10 mM glucose was decreased and delayed by PiC down-regulation compared with that in control ( Figure 3A) . Average values calculated using the data from Figure 3 Figure 4(A) . PiC down-regulation decreased mitochondrial ATP production by 50-60 % at [P i ] ranging from 0.001 to 10 mM. ATP production in all groups reached maximum rates above ∼ 3 mM of [P i ], which indicates that the PiC amount regulates the maximal rate of mitochondrial ATP production. On the other hand, K m values of [P i ] for ATP production were similar (∼ 0.05 mM). Mitochondrial ATP production in the presence of various mitochondrial substrates and inhibitors of the respiratory chain is shown in Table 3 . ATP production in the presence of succinate was completely inhibited by antimycin A, a complex III inhibitor, in both control and PiC down-regulated INS-1 cells. PiC siRNAs decreased ATP production in the presence of pyruvate and malate by 42-58 %, succinate plus rotenone by 46-62 % and TMPD (N,N,N ,N -tetramethyl-p-phenylenediamine) plus ascorbate by 61-62 %, showing that ATP production by electrons rendered at complex I, complex II and complex IV is suppressed to a similar degree. In spite of significant downregulation of ATP production, PiC down-regulation did not affect ψ m of isolated mitochondria measured with Safranin O in the presence of succinate ( Figure 4B ).
Effects of PiC down-regulation on expression of mitochondrial respiratory chain proteins
Immunoblotting using lysates of whole INS-1 cells revealed that transfection of PiC siRNAs did not change the expression of complex I, III, IV or V of mitochondrial respiratory chain proteins ( Figure 5 ).
DISCUSSION
In the present study, the mitochondrial phosphate carrier (PiC) was revealed to play an important role in metabolism-secretion coupling of pancreatic β-cells by using INS-1 cells and PiC siRNA. PiC down-regulation brings about reduction in mitochondrial ATP production by mitochondrial fuels, resulting in reduced glucose-induced [Ca 2+ ] i elevation and impaired GSIS. In pancreatic β-cells, ATP increase is slight and ADP decrease is prominent via an increase in glucose levels beyond the triggering level of insulin secretion. In addition, the ATP/ADP ratio is well-correlated with GSIS rather than the absolute value of ATP [22, 23] . PiC down-regulation decreased the ATP/ADP ratio in the presence of high glucose, which causes insufficient closure of K ATP channels, a decrease in [Ca 2+ ] i elevation by glucose ( Figures 3A and 3B) , and suppression of GSIS (Figure 2) .
Insulin secretion at 10 mM glucose was similar to that at 30 mM K + and 2 mM glucose in the control samples. In contrast, in PiC down-regulated INS-1 cells, GSIS is lower than depolarizationinduced insulin secretion, which suggests specific effects of PiC on metabolism-secretion coupling (Figure 2) . However, ∼ 25 % suppression of depolarization-induced insulin secretion, which is modest compared with GSIS, was observed in PiC down-regulated INS-1 cells. Measurements revealed that [Ca 2+ ] i in the presence of 2 mM glucose and 30 mM K + was reduced by PiC downregulation ( Figures 3C and 3D ), which plays a role in reduced depolarization-induced insulin secretion by PiC down-regulation. Depolarization reduced the ATP/ADP ratio in the presence of a basal level of glucose in control samples, which accords with a previous study where an increase in [Ca 2+ ] i causes a larger consumption than production of ATP [24] (Table 2B ). The ATP/ADP ratio was also reduced by depolarization at 2 mM glucose in PiC down-regulated INS-1 cells, although the suppression was lower than that in control samples, which may reflect a smaller elevation of [Ca 2+ ] i than in the control. In addition, in contrast with a significant suppression of the ATP/ADP ratio at high glucose concentrations by PiC down-regulation, in the presence of a basal level of glucose, PiC down-regulation did not affect the ATP/ADP ratio in INS-1 cells. An incomplete compensatory effect derived from PiC down-regulation, which is valid in a basal supply of substrate to mitochondria but deteriorates in an accelerated supply at high glucose, might save ATP consumption and maintain the basal ratio of ATP/ADP. PiC, which is required for mitochondrial ATP production, has two isoforms. PiC-A is expressed in skeletal and cardiac muscle whereas PiC-B is expressed ubiquitously. AAC (ATP/ADP carrier), which is also required for mitochondrial ATP production, has isoforms including AAC1 (SLC25A4), AAC2 (SLC25A5) and AAC3 (SLC25A6). Interestingly, these isoforms, except AAC2, expression of which is absent or scarce in most tissues, distribute similarly to the PiC isoforms: AAC1 is expressed in skeletal and cardiac muscle, and AAC3 is expressed ubiquitously. These distributions imply that ubiquitously-expressed PiC-B and AAC3 may meet stable energy requirement, and PiC-A and AAC1, which are expressed exclusively in muscle, meet higher and prompt energy demands for muscle contraction. In the present study, we demonstrate that PiC-B is the dominant isoform of PiC whereas PiC-A is scarcely expressed in INS-1 cells and rat islets ( Figure 1A) , which may reflect less prompt energy demand in β-cells compared with that in muscles. Mitochondrial ATP is produced by complex V (ATP synthase), which is driven by protonmotive force generated by proton extrusion during transport of high-energy electrons in the respiratory chain. In the present study, mitochondrial ATP production in the presence of mitochondrial fuel increased according to the raised extramitochondrial phosphate concentration ([P i ] e ), and reached maximum rate above ∼ 3 mM of [P i ] e , which was decreased by 50-60 % without affecting the K m value of [P i ] e for ATP production by ∼ 40 % reduction in PiC protein. The physiological intracellular [P i ] in heart determined by methods including 31 P NMR is ∼ 1 mM at rest and increases to ∼ 10 mM depending on the metabolic state [25] [26] [27] . Levels of P i in islets are ∼ 20 mmol/kg of dry weight tissue [28] , which corresponds to ∼ 10 mM by conversion [29] . Taken together, the rate of mitochondrial ATP production might be barely affected by a physiological change of [P i ] e but be evidently affected by alteration of the amount of PiC protein. In addition, reduction in ATP production by down-regulation of PiC also suggests that compensatory supply of P i to mitochondria by other mitochondrial phosphate carriers including DIC (SLC25A10) [30, 31] does not occur, which is supported by no apparent effect of PiC down-regulation on DIC expression ( Figure 1E ). These results accord with the first description that PiC dysfunction impairs the synthesis of ATP [15] .
Intramitochondrial P i is thought to affect oxidative phosphorylation at multiple sites [16] . To find specific defective sites in the respiratory chain in PiC down-regulated INS-1 cells, mitochondrial ATP production was examined in the presence of various substrates and inhibitors. Pyruvate and malate, which are metabolized in mitochondria to generate NADH, render electrons at complex I. In the presence of rotenone, a complex I inhibitor, succinate renders electrons directly to complex II via FADH 2 . TMPD is an artificial electron donor that can transfer electrons to cytochrome c. TMPD reduced by ascorbate renders electrons to cytochrome c, which transfers electrons to complex IV. Reduction of ATP production by down-regulation of PiC in the presence of pyruvate plus malate, succinate plus rotenone and TMPD plus ascorbate were all suppressed similarly by 50-60 % (Table 3) . These results indicate that reduction in ATP production by down-regulation of PiC may well be derived from a defective site downstream of complex IV and that a defective site upstream of complex IV, if present, does not play a prominent role. Moreover, immunoblotting revealed that expressions of respiratory chain proteins including complex I, III, IV and V were not affected by PiC silencing. Considered together, silencing of PiC seems to suppress mitochondrial ATP production not by affecting mitochondrial biogenesis, but by restricting P i supply to complex V.
Inhibition of complex V by oligomycin reduces ATP production with hyperpolarization of ψ m [32, 33] , which may be derived from the fact that complex V is a protonophore and its inhibition affects electrogenic H + influx to mitochondria specifically and directly affects ψ m . In contrast, PiC is electroneutral due to symport of H + and negatively charged P i or antiport of OH − and negatively charged P i and does not directly affect ψ m . ATP generation in complex V is driven by protonmotive force ( p), which has two components: electrical membrane potential ( ψ m ) and the difference between the cytosolic and matrix pH ( pH) [34, 35] . P i plays regulatory roles in oxidative phosphorylation by affecting p. An increase in [P i ] e reduces pH [34, [36] [37] [38] due to an increase in co-transport of P i and protons from cytosol into mitochondrial matrix through PiC. On the other hand, ψ m is increased by an increase in [P i ] e of less than ∼ 2 mM, but reaches a plateau at [P i ] e above ∼ 2 mM [16, 34, 38] . Increases in ψ m owing to increases in [P i ] e is not fully elucidated, but some explanations are proposed. An electroneutral influx of protons (H + ) accompanying negatively charged substrates such as P i does not directly affect ψ m but produces a reduction in pH that promotes proton extrusion by the respiratory chain to maintain p and eventually increases ψ m [35] . Bose et al. [16] provided another explanation: an increase in the influx of P i activates intramitochondrial NADH production and NADH supply to complex I and also promotes the ability to generate p by improving the coupling of electron transport between cytochrome b and cytochrome c, which eventually increases ψ m . Interestingly, in the present study, ∼ 40 % reduction in the protein level of PiC did not affect glucose-induced hyperpolarization of the mitochondrial inner membrane in spite of a reduction in ATP production. It is possible that the reduction in P i influx by down-regulation of PiC in the present study is within a range of P i influx which does not affect ψ m as with higher [P i ] e . In addition, our results were derived from sustained downregulation of P i influx to mitochondria, as experiments were performed 48 h after transfection of PiC siRNA in contrast with the acute alteration of P i influx by manipulation of [P i ] e in previous studies, which may permit adaptation of ψ m to maintain p.
It has been generally reported that the contribution of ψ m to p is 80-85 % [34, 35, [37] [38] [39] [40] [41] [42] [43] [44] [45] or more [16] and that of pH is relatively small, which indicates that the alteration in p by down-regulation of PiC in the present study is small considering the non-detectable affect on ψ m . Therefore the supply of P i to complex V may well be a critical rate-limiting step for ATP production independent of p. The results in the present study demonstrate the critical role of P i influx to mitochondria in ATP production and metabolism-secretion coupling in pancreatic β-cells.
